Jeffrey M. Leiden, CEO & President at VERTEX PHARMACEUTICALS INC / MA (VRTX), sold 9,434 shares at $210.00 ($2.0M) on 2019-11-15, disclosed to the SEC on 2019-11-19.
Open-market sale of $2.0M VRTX by CEO & President. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $210.00 | 1,683 | $353K | 17.8% |
| 2 | $210.00 | 3,317 | $697K | 35.2% |
| 3 | $210.00 | 1,493 | $314K | 15.8% |
| 4 | $210.00 | 2,941 | $618K | 31.2% |
| Total | $210.00 avg | 9,434 | $2.0M | 100% |
| Filing → |
| VRTX | SELL | 2025-11-17 | $64.1M | — | Filing → |
| VRTX | SELL | 2024-09-04 | $1.9M | — | Filing → |
| VRTX | SELL | 2024-02-16 | $7.6M | — | Filing → |